There have been a lot of eyes on Hipgnosis Songs Fund (HSF) this year. The UK-listed fund, once the most active acquisitive entity in music rights, has paused its buying of catalogs over the past 12 months, and hasn’t raised any new share capital for rights buyouts during this period. Today (December 8), HSF has announced its half-year results for the six months to end of September 2022, with a number of positive signs, both for HSF investors and for the music rights business at large.
